Occupational Health
Workers exposed to cystic fibrosis gene therapy rarely develop adverse effects
Published in Gene Therapy Weekly, February 10th, 2005
"A study was conducted to assess health care worker exposure to tgAAVCF during the aerosolized administration of this experimental gene transfer agent in clinical trials for the treatment of cystic fibrosis (CF). tgAAVCF is a recombinant adeno-associated virus (AAV) genetically engineered to contain the human CF transmembrane conductance regulator cDNA," scientists writing in the journal Annals of Occupational Hygiene report.
"Study subjects included 8 health care workers involved in the administration of tgAAVCF in a phase II study and 12 control health care...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-02-10)
More Articles from Gene Therapy Weekly
- Cancer Therapy
Oblimersen and vinorelbine diminish malignant lung tumors in murine models - Gastroenterology
Somatostatin receptor subtype 2 abates pancreatic cancer vessel formation - Oncology
Recent findings illuminate research in oncology - Oncology
Screened polymer libraries highlight optimal cancer gene therapy vectors - Oncology
Small interfering RNA augments hypoxia and radiation induced tumor cell death - Apoptosis
NDRG1 gene is necessary for p53-dependent apoptosis - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
